Watch CBS News

Medtronic Profit Rises, Revenue Falls In Q2

NEW YORK (AP) — Medtronic PLC's fiscal second-quarter profit more than doubled on higher sales of its heart and surgical devices. But revenue fell short of Wall Street expectations, helping to drag shares lower.

The Dublin-based company's stock fell more than 8 percent in morning trading Tuesday.

The medical device company earned $1.12 billion, or 80 cents per share. Earnings, adjusted for amortization costs and restructuring costs, came to $1.12 per share. The results topped Wall Street expectations. The average estimate of 18 analysts surveyed by Zacks Investment Research was for earnings of $1.11 per share.

Revenue rose 4 percent to $7.35 billion in the period, which missed Street forecasts. Seventeen analysts surveyed by Zacks expected $7.46 billion.

The revenue boost came from a broad range of divisions. Revenue from the cardiac and vascular unit, which includes implantable heart devices and valves, rose 4 percent to $2.58 billion. Revenue from minimally invasive therapies, which includes patient monitoring and surgical devices, rose 5 percent to $2.47 billion. The company's restorative therapies unit saw revenue rise 4 percent to $1.83 billion, while the diabetes care unit saw revenue rise 3 percent to $462 million.

Medtronic expects full-year earnings in the range of $4.55 to $4.60 per share.

Medtronic shares fell $6.70, or 8.3 percent, to $73.88 in morning trading Tuesday. Its shares have fallen more than 3 percent in the last 12 months.

(© Copyright 2016 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.